Ipca Laboratories Limited

NSEI:IPCALAB Voorraadrapport

Marktkapitalisatie: ₹403.7b

Ipca Laboratories Dividenden en inkoop

Dividend criteriumcontroles 3/6

Ipca Laboratories is een dividendbetalend bedrijf met een huidig rendement van 0.25% dat ruimschoots wordt gedekt door de winst. Volgende betalingsdatum is op 10th December, 2024 met een ex-dividenddatum van 27th November, 2024.

Belangrijke informatie

0.3%

Dividendrendement

n/a

Terugkoop Rendement

Totaal aandeelhoudersrendementn/a
Toekomstig dividendrendement0.4%
Dividendgroei2.4%
Volgende betaaldatum dividend10 Dec 24
Ex-dividenddatum27 Nov 24
Dividend per aandeel₹4.000
Uitbetalingsratio15%

Recente updates van dividend en inkoop

Ipca Laboratories (NSE:IPCALAB) Is Paying Out A Dividend Of ₹2.00

Nov 17
Ipca Laboratories (NSE:IPCALAB) Is Paying Out A Dividend Of ₹2.00

Recent updates

Ipca Laboratories (NSE:IPCALAB) Is Paying Out A Dividend Of ₹2.00

Nov 17
Ipca Laboratories (NSE:IPCALAB) Is Paying Out A Dividend Of ₹2.00

Earnings Tell The Story For Ipca Laboratories Limited (NSE:IPCALAB)

Sep 10
Earnings Tell The Story For Ipca Laboratories Limited (NSE:IPCALAB)

Ipca Laboratories' (NSE:IPCALAB) Solid Earnings Have Been Accounted For Conservatively

Jun 07
Ipca Laboratories' (NSE:IPCALAB) Solid Earnings Have Been Accounted For Conservatively

Ipca Laboratories Limited (NSE:IPCALAB) Not Lagging Market On Growth Or Pricing

May 24
Ipca Laboratories Limited (NSE:IPCALAB) Not Lagging Market On Growth Or Pricing

Investors Interested In Ipca Laboratories Limited's (NSE:IPCALAB) Earnings

Feb 07
Investors Interested In Ipca Laboratories Limited's (NSE:IPCALAB) Earnings

Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly

Jan 09
Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly

Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?

Aug 20
Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?

Ipca Laboratories (NSE:IPCALAB) Has A Pretty Healthy Balance Sheet

Feb 28
Ipca Laboratories (NSE:IPCALAB) Has A Pretty Healthy Balance Sheet

Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly

Sep 20
Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly

Estimating The Intrinsic Value Of Ipca Laboratories Limited (NSE:IPCALAB)

Aug 31
Estimating The Intrinsic Value Of Ipca Laboratories Limited (NSE:IPCALAB)

Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?

Jun 22
Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?

Calculating The Fair Value Of Ipca Laboratories Limited (NSE:IPCALAB)

May 28
Calculating The Fair Value Of Ipca Laboratories Limited (NSE:IPCALAB)

Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?

Mar 15
Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Ipca Laboratories (NSE:IPCALAB) Is Using Debt Reasonably Well

Sep 20
These 4 Measures Indicate That Ipca Laboratories (NSE:IPCALAB) Is Using Debt Reasonably Well

Is Now The Time To Put Ipca Laboratories (NSE:IPCALAB) On Your Watchlist?

Aug 09
Is Now The Time To Put Ipca Laboratories (NSE:IPCALAB) On Your Watchlist?

Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?

Jun 08
Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?

How Does Ipca Laboratories Limited (NSE:IPCALAB) Stand Up To These Simple Dividend Safety Checks?

Mar 26
How Does Ipca Laboratories Limited (NSE:IPCALAB) Stand Up To These Simple Dividend Safety Checks?

Do Ipca Laboratories's (NSE:IPCALAB) Earnings Warrant Your Attention?

Mar 13
Do Ipca Laboratories's (NSE:IPCALAB) Earnings Warrant Your Attention?

Trade Alert: The Compliance Officer Of Ipca Laboratories Limited (NSE:IPCALAB), Harish Kamath, Has Sold Some Shares Recently

Feb 28
Trade Alert: The Compliance Officer Of Ipca Laboratories Limited (NSE:IPCALAB), Harish Kamath, Has Sold Some Shares Recently

Ipca Laboratories Limited's (NSE:IPCALAB) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Feb 23
Ipca Laboratories Limited's (NSE:IPCALAB) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Does Ipca Laboratories' (NSE:IPCALAB) CEO Salary Compare Well With Industry Peers?

Feb 11
Does Ipca Laboratories' (NSE:IPCALAB) CEO Salary Compare Well With Industry Peers?

Could The Ipca Laboratories Limited (NSE:IPCALAB) Ownership Structure Tell Us Something Useful?

Jan 30
Could The Ipca Laboratories Limited (NSE:IPCALAB) Ownership Structure Tell Us Something Useful?

The Ipca Laboratories (NSE:IPCALAB) Share Price Is Up 264% And Shareholders Are Boasting About It

Jan 15
The Ipca Laboratories (NSE:IPCALAB) Share Price Is Up 264% And Shareholders Are Boasting About It

Komende dividendbetaling

VandaagNov 23 2024Ex Dividend DatumNov 27 2024Betaaldatum dividendDec 10 202413 days vanaf ex-dividendKoop in de volgende 4 days om het komende dividend te ontvangen

Stabiliteit en groei van betalingen

Dividenden ophalen

Stabiel dividend: De dividendbetalingen van IPCALAB zijn de afgelopen 10 jaar volatiel geweest.

Groeiend dividend: De dividendbetalingen van IPCALAB zijn de afgelopen 10 jaar gestegen.


Dividendrendement versus markt

Ipca Laboratories Dividendrendement versus markt
Hoe verhoudt IPCALAB dividendrendement zich tot de markt?
SegmentDividendrendement
Bedrijf (IPCALAB)0.3%
Markt onderkant 25% (IN)0.3%
Markt Top 25% (IN)1.2%
Gemiddelde industrie (Pharmaceuticals)0.7%
Analist prognose (IPCALAB) (tot 3 jaar)0.4%

Opmerkelijk dividend: Het dividend van IPCALAB ( 0.25% ) is niet noemenswaardig vergeleken met de onderste 25% van de dividendbetalers op de Indian markt ( 0.25% ).

Hoog dividend: Het dividend IPCALAB ( 0.25% ) is laag vergeleken met de top 25% van dividendbetalers in de Indian markt ( 1.15% ).


Winstuitkering aan aandeelhouders

Verdiendekking: Met zijn lage payout ratio ( 15.4% ) worden de dividendbetalingen van IPCALAB ruimschoots gedekt door de winst.


Contante uitbetaling aan aandeelhouders

Kasstroomdekking: Met zijn lage cash payout ratio ( 11.3% ) worden de dividendbetalingen van IPCALAB volledig gedekt door kasstromen.


Ontdek bedrijven met een sterk dividend